Flex Conference (Physical / Digital)

International Conference on Hematology and Oncology Collaboration - (ICHOC-26)

11th - 12th November 2026 , Manila - Philippines

Registration Options

Access Flexible Participation Categories

Call For Papers

The (ICHOC-26) emphasizes interdisciplinary collaboration by bringing together experts from diverse fields. It encourages research that integrates multiple perspectives to address complex global challenges.

Key areas such as Hematology are explored to promote cross-domain knowledge exchange and collaborative innovation.

Authors are invited to submit papers addressing, but not limited to, the following areas:

  • Innovative treatments in hematology
  • Collaboration in oncology research
  • Patient-centered care in hematology
  • Emerging therapies for blood disorders
  • Oncology clinical trials and outcomes
  • Hematology and oncology education strategies
  • Multidisciplinary approaches to cancer care
  • Genetic factors in hematological diseases
  • Palliative care in oncology settings
  • Advancements in blood transfusion practices
  • Quality of life in cancer patients
  • Ethical considerations in oncology research
  • Telemedicine in hematology and oncology
  • Health disparities in cancer treatment
  • Novel biomarkers in hematological malignancies
  • Immunotherapy advancements in oncology
  • Patient advocacy in hematology care
  • Global perspectives on cancer treatment
  • Integrative approaches to cancer therapy
  • Future directions in hematology and oncology

Assessment

All submissions will undergo peer review to ensure quality and interdisciplinary relevance. Accepted papers will be presented and considered for publication in journals and conference proceedings.

Registration

Registering for the conference provides access to keynote sessions, technical presentations, and networking opportunities with global experts.

Publication

Publishing through the conference enhances the visibility of your research and connects your work with a broader academic audience.